PM

Peter Marks

Noxopharm Limited | Non-Executive Director, Non-Executive Deputy Chairman
Mr Peter has over 40 years' experience in corporate advisory and investment banking. Over the course of his career, he has experience in capital raisings, IPOs, cross border, M&A transactions, corporate underwriting and venture capital transactions for companies in Australia, the United States and Israel. He has been involved in a range of transactions with a focus in the life sciences, biotechnology, medical technology and tech segments. Peter has served as both an Executive and Non-Executive Director of a number of different entities which have been listed on the ASX, NASDAQ, and AIM markets.

Companies and Roles

Company
Title
Tenure
Since
NOX
Noxopharm Limited
  • Non-Executive Director
  • Non-Executive Deputy Chairman
10yrs, 5mthMar 2016
ATH
Alterity Therapeutics Limited
  • Non-Executive Director
21yrs, 1mthJul 2005
PM1
Palisade Metals Ltd
  • Non-Executive Director
5yrs, 8mthDec 2020
EG1
Evergold Minerals Limited
  • Non-Executive Director
4yrs, 7mthJan 2022

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
PM1
Palisade Metals Ltd
01/04/262,700,000708,0301,151,515N/A
01/04/262,700,000708,0301,151,515N/A
ATH
Alterity Therapeutics Limited
17/09/25N/A9,004,15032,987,013N/A
NOX
Noxopharm Limited
30/06/25N/A900,000N/AN/A
EG1
Evergold Minerals Limited
30/06/25N/A12,000,0005,000,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
PM1
Palisade Metals Ltd
30/06/26
Expiry
700,000$0.055$38,500As advised by the company
30/06/26
Expiry
700,000$0.055$38,500As advised by the company
PM1
Palisade Metals Ltd
01/04/26
Issued
151,515$0.100$15,151Placement
PM1
Palisade Metals Ltd
01/04/26
Issued
303,030$0.165$49,999Placement
01/04/26
Issued
151,515$0.100$15,151Placement